Evidence map›Paper›PMID 22427926›Full record

ArticlePloS one2012

Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase.

Zhihong Li, Chunxue Lu, Bo Peng, Hao Zeng, Zhiguan Zhou, Yimou Wu, Guangming Zhong

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Efficacy of Pgp3 vaccination forFrontiers in immunology · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Update on Chlamydia trachomatis Vaccinology.Clinical and vaccine immunology : CVI · 2017
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Zhihong LiDepartment of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Chunxue Lu
Bo Peng
Hao Zeng
Zhiguan Zhou
Yimou Wu
Guangming Zhong
University of South China · CNThe University of Texas Health Science Center at San Antonio · USCentral South University · CNSecond Xiangya Hospital of Central South University · CN

Funding

Chlamydia trachomatis proteomicsR01AI064537 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHONG, GUANGMING · 2005 to 2015
$3.5M
NIAID NIH HHS R01 AI064537NIAID NIH HHS R01AI64537
6 · The paper itself

Abstract

We evaluated 7 C. muridarum ORFs for their ability to induce protection against chlamydial infection in a mouse intravaginal infection model. These antigens, although encoded in C. muridarum genome, are transcriptionally regulated by a cryptic plasmid that is known to contribute to C. muridarum pathogenesis. Of the 7 plasmid-regulated ORFs, the chlamydial glycogen phosphorylase or GlgP, when delivered into mice intramuscularly, induced the most pronounced protective immunity against C. muridarum intravaginal infection. The GlgP-immunized mice displayed a significant reduction in vaginal shedding of live organisms on day 14 after infection. The protection correlated well with a robust C. muridarum-specific antibody and a Th1-dominant T cell responses, which significantly reduced the severity but not overall incidence of hydrosalpinx. The GlgP-induced partial protection against upper genital tract pathology suggests that GlgP may be considered a component for a multi-subunit vaccine. These results have demonstrated that intramuscular immunization of mice with purified proteins can be used to identify vaccine antigens for preventing intravaginal infection with C. trachomatis in humans.

Indexed as

Analysis of VarianceAnimalsAntibodies, BacterialAntigens, BacterialBlotting, WesternChlamydia InfectionsChlamydia muridarumCross ReactionsEnzyme-Linked Immunosorbent AssayFemaleGlycogen PhosphorylaseHeLa CellsHumansInjections, IntramuscularMiceMicroscopy, FluorescenceAntibodies, BacterialAntigens, BacterialGlycogen Phosphorylase

Identifiers

PMID22427926
PMCPMC3299733
OpenAlexW2091642449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.